What is the cost of gemcitabine?
What is the cost of gemcitabine?
GEMCITABINE is a chemotherapy drug. This medicine is used to treat many types of cancer like breast cancer, lung cancer, pancreatic cancer, and ovarian cancer. The lowest GoodRx price for the most common version of gemcitabine is around $35.41, 79% off the average retail price of $176.52.
What is gemcitabine used for?
Gemcitabine is also used to treat pancreatic cancer that has spread to other parts of the body and has not improved or worsened after treatment with another medication. Gemcitabine is in a class of medications called antimetabolites. It works by slowing or stopping the growth of cancer cells in your body.
Is gemcitabine an immunosuppressant?
We conclude that gemcitabine therapy (1) is not immunosuppressive and (2) may enhance responses to specific vaccines or immunotherapy administered to activate or support immune responses directed toward driving effector immunity to cancer cells.
Is gemcitabine an immunotherapy drug?
Drug Type: Gemcitabine is an anti-cancer (“antineoplastic” or “cytotoxic”) chemotherapy drug. Gemcitabine is classified as an antimetabolite.
How quickly does gemcitabine work?
How you have gemcitabine. You have gemcitabine into your bloodstream. It takes about 30 minutes.
How effective is gemcitabine for lung cancer?
Gemcitabine for lung cancer is an effective treatment when combined with cisplatin , but otherwise, it has no marked effect. Positive results for this combination qualify it only to be one of several options for the treatment of non-small cell lung cancer, as opposed to a recommended treatment.
How effective is gemcitabine for pancreatic cancer?
Gemcitabine is effective for the treatment of pancreatic cancer but often results in decreased white blood cells, the cells that help the body fight infection and combat anemia.
The medicine Gemcitabine is used to treat Pancreatic ductal carcinoma
What are the uses of gemcitabine and docetaxel?
The anticancer agents gemcitabine and docetaxel are used to treat various malignant tumours, including non-small cell lung cancer and breast cancer. Combination chemotherapy with gemcitabine and docetaxel (GD) has been shown to be effective for metastatic leiomyosarcoma and other STS [ 5, 6, 7, 8, 9, 10 ].